APLS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 6.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $14,509,679.38

Apellis Pharmaceuticals Insider Trading History Chart

Apellis Pharmaceuticals Share Price & Price History

^$41.03

+0.30 (1.20%)

As of 05/14/2026 03:30 PM ET

Apellis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/11/2026	Mark Jeffrey DeLong	Insider	Sell	368	$22.15	$8,151.20	114,591
1/22/2026	Caroline Baumal	Insider	Sell	2,797	$21.77	$60,890.69	86,527
1/22/2026	Cedric Francois	CEO	Sell	27,192	$21.77	$591,969.84	286,045
1/22/2026	David O. Watson	General Counsel	Sell	7,832	$21.77	$170,502.64	88,531
1/22/2026	James George Chopas	CAO	Sell	2,064	$21.77	$44,933.28	49,805
1/22/2026	Mark Jeffrey DeLong	Insider	Sell	3,371	$21.77	$73,386.67	78,353
1/22/2026	Nur Nicholson	Insider	Sell	7,725	$21.77	$168,173.25	71,118
1/22/2026	Pascal Deschatelets	Insider	Sell	5,928	$21.77	$129,052.56	1,151,382
1/22/2026	Timothy Eugene Sullivan	CFO	Sell	10,287	$21.77	$223,947.99	93,901
1/20/2026	Caroline Baumal	Insider	Sell	1,882	$19.79	$37,244.78	89,324
1/20/2026	Cedric Francois	CEO	Sell	8,182	$19.79	$161,921.78	313,237
1/20/2026	David O. Watson	General Counsel	Sell	2,475	$19.79	$48,980.25	96,363
1/20/2026	James George Chopas	CAO	Sell	726	$19.79	$14,367.54	51,869
1/20/2026	Mark Jeffrey DeLong	Insider	Sell	1,334	$19.79	$26,399.86	81,724
1/20/2026	Nur Nicholson	Insider	Sell	2,203	$19.79	$43,597.37	78,843
1/20/2026	Pascal Deschatelets	Insider	Sell	909	$19.79	$17,989.11	1,157,310
1/20/2026	Timothy Eugene Sullivan	CFO	Sell	2,892	$19.79	$57,232.68	104,188
1/13/2026	Cedric Francois	CEO	Sell	10,186	$22.19	$226,027.34	321,419
1/13/2026	David O. Watson	General Counsel	Sell	5,780	$22.19	$128,258.20	98,838
1/13/2026	James George Chopas	CAO	Sell	873	$22.19	$19,371.87	52,595
1/13/2026	Mark Jeffrey DeLong	Insider	Sell	1,780	$22.19	$39,498.20	83,058
1/13/2026	Nur Nicholson	Insider	Sell	2,618	$22.19	$58,093.42	81,046
1/13/2026	Pascal Deschatelets	Insider	Sell	2,277	$22.19	$50,526.63	1,158,219
1/13/2026	Timothy Eugene Sullivan	CFO	Sell	3,856	$22.19	$85,564.64	107,080
12/16/2025	David O. Watson	General Counsel	Sell	5,000	$24.49	$122,450.00	103,730
11/17/2025	David O. Watson	General Counsel	Sell	5,000	$20.06	$100,300.00	108,730
10/21/2025	Timothy Eugene Sullivan	CFO	Sell	10,000	$28.03	$280,300.00	110,936
10/16/2025	David O. Watson	General Counsel	Sell	5,000	$25.22	$126,100.00	113,730
10/10/2025	A. Sinclair Dunlop	Director	Sell	31,092	$23.72	$737,502.24	3,837
9/19/2025	A. Sinclair Dunlop	Director	Sell	31,092	$22.95	$713,561.40	68,908
9/16/2025	David O. Watson	General Counsel	Sell	5,000	$24.34	$121,700.00	118,730
9/15/2025	James George Chopas	CAO	Sell	189	$24.19	$4,571.91	53,468
9/2/2025	James George Chopas	CAO	Sell	548	$28.08	$15,387.84	53,657
8/28/2025	Cedric Francois	CEO	Sell	49,963	$28.39	$1,418,449.57	307,946
8/27/2025	Cedric Francois	CEO	Sell	175,037	$28.19	$4,934,293.03	357,909
8/18/2025	David O. Watson	General Counsel	Sell	5,000	$27.80	$139,000.00	123,730
7/17/2025	Cedric Francois	CEO	Sell	19,725	$20.21	$398,642.25	331,605
7/16/2025	David O. Watson	General Counsel	Sell	5,000	$19.55	$97,750.00	128,730
7/15/2025	Cedric Francois	CEO	Sell	1,900	$20.09	$38,171.00	342,333
7/14/2025	Cedric Francois	CEO	Sell	137,465	$20.19	$2,775,418.35	343,433
6/16/2025	David O. Watson	General Counsel	Sell	5,000	$18.77	$93,850.00	133,730
3/17/2025	James George Chopas	CAO	Sell	183	$24.82	$4,542.06	47,955
3/5/2025	David O. Watson	General Counsel	Sell	5,569	$25.10	$139,781.90	138,730
2/11/2025	Mark Jeffrey DeLong	Insider	Sell	363	$28.54	$10,360.02	83,945
1/29/2025	Cedric Francois	CEO	Sell	2,824	$29.52	$83,364.48	415,695
1/29/2025	David O. Watson	General Counsel	Sell	695	$29.52	$20,516.40	144,299
1/29/2025	Nur Nicholson	Insider	Sell	825	$29.52	$24,354.00	83,664
1/29/2025	Timothy Eugene Sullivan	CFO	Sell	546	$29.52	$16,117.92	128,665
1/22/2025	Cedric Francois	CEO	Sell	13,551	$30.43	$412,356.93	418,519
1/22/2025	David O. Watson	General Counsel	Sell	3,323	$30.43	$101,118.89	144,994
1/22/2025	James George Chopas	CAO	Sell	1,096	$30.43	$33,351.28	48,138
1/22/2025	Nur Nicholson	Insider	Sell	3,948	$30.43	$120,137.64	84,489
1/22/2025	Timothy Eugene Sullivan	CFO	Sell	3,088	$30.43	$93,967.84	129,211
1/17/2025	Cedric Francois	CEO	Sell	6,007	$29.96	$179,969.72	301,408
1/17/2025	David O. Watson	General Counsel	Sell	2,201	$29.96	$65,941.96	105,555
1/17/2025	James George Chopas	CAO	Sell	715	$29.96	$21,421.40	36,643
1/17/2025	Nur Nicholson	Insider	Sell	2,145	$29.96	$64,264.20	52,011
1/17/2025	Timothy Eugene Sullivan	CFO	Sell	1,730	$29.96	$51,830.80	86,370
1/13/2025	Cedric Francois	CEO	Sell	6,247	$28.70	$179,288.90	307,415
1/13/2025	David O. Watson	General Counsel	Sell	4,965	$28.70	$142,495.50	107,756
1/13/2025	James George Chopas	CAO	Sell	783	$28.70	$22,472.10	37,358
1/13/2025	Jeffrey Eisele	Insider	Sell	264	$28.70	$7,576.80	56,881
1/13/2025	Timothy Eugene Sullivan	CFO	Sell	2,170	$28.70	$62,279.00	88,100
1/6/2025	Caroline Baumal	Insider	Sell	2,816	$33.81	$95,208.96	55,560
12/23/2024	Jeffrey Eisele	Insider	Sell	63	$33.09	$2,084.67	57,145
9/16/2024	A. Sinclair Dunlop	Director	Sell	37,000	$36.23	$1,340,510.00	100,000
6/21/2024	A. Sinclair Dunlop	Director	Sell	37,000	$39.24	$1,451,880.00	136,998
5/8/2024	Pascal Deschatelets	Insider	Sell	78,907	$42.35	$3,341,711.45	1,115,983
4/8/2024	Pascal Deschatelets	Insider	Sell	69,107	$54.17	$3,743,526.19	1,115,983
4/1/2024	Timothy Eugene Sullivan	CFO	Sell	4,000	$58.66	$234,640.00	93,338
3/19/2024	A. Sinclair Dunlop	Director	Sell	18,681	$57.18	$1,068,179.58	173,998
3/18/2024	Mark Jeffrey DeLong	Insider	Sell	9,913	$56.90	$564,049.70	54,693
3/15/2024	James George Chopas	CAO	Sell	184	$56.46	$10,388.64	38,883
3/13/2024	Nur Nicholson	Insider	Sell	11,220	$57.56	$645,823.20	56,287
3/1/2024	Cedric Francois	CEO	Sell	250,000	$64.11	$16,027,500.00	313,662
3/1/2024	Timothy Eugene Sullivan	CFO	Sell	6,000	$63.22	$379,320.00	93,338
2/12/2024	Adam J. Townsend	Insider	Sell	1,148	$67.77	$77,799.96	92,453
2/12/2024	Cedric Francois	CEO	Sell	3,962	$67.77	$268,504.74	313,662
2/12/2024	David O. Watson	General Counsel	Sell	781	$67.77	$52,928.37	103,390
2/12/2024	Timothy Eugene Sullivan	CFO	Sell	1,431	$67.77	$96,978.87	93,338
1/29/2024	Cedric Francois	CEO	Sell	2,843	$64.14	$182,350.02	317,624
1/29/2024	David O. Watson	General Counsel	Sell	906	$64.14	$58,110.84	104,171
1/29/2024	Nur Nicholson	Insider	Sell	835	$64.14	$53,556.90	67,507
1/22/2024	Adam J. Townsend	Insider	Sell	3,413	$65.00	$221,845.00	94,507
1/22/2024	Cedric Francois	CEO	Sell	13,431	$65.00	$873,015.00	320,467
1/22/2024	David O. Watson	General Counsel	Sell	4,184	$65.00	$271,960.00	105,077
1/22/2024	James George Chopas	CAO	Sell	1,061	$65.00	$68,965.00	39,067
1/22/2024	Timothy Eugene Sullivan	CFO	Sell	3,551	$65.00	$230,815.00	95,675
1/16/2024	Cedric Francois	CEO	Sell	7,851	$66.81	$524,525.31	333,898
1/16/2024	David O. Watson	General Counsel	Sell	4,240	$66.81	$283,274.40	109,261
1/16/2024	James George Chopas	CAO	Sell	864	$66.81	$57,723.84	40,128
1/16/2024	Jeffrey Eisele	Insider	Sell	438	$66.81	$29,262.78	72,650
1/16/2024	Timothy Eugene Sullivan	CFO	Sell	2,235	$66.81	$149,320.35	99,226
1/4/2024	Caroline Baumal	Insider	Sell	2,751	$60.05	$165,197.55	32,931
12/26/2023	Jeffrey Eisele	Insider	Sell	68	$57.86	$3,934.48	53,815
12/19/2023	David O. Watson	General Counsel	Sell	3,905	$57.23	$223,483.15	89,753
12/1/2023	Lukas Scheibler	Insider	Sell	10,000	$60.00	$600,000.00	68,299
11/21/2023	Cedric Francois	CEO	Sell	5,000	$48.80	$244,000.00	269,655
11/17/2023	Alec Machiels	Director	Sell	1,250	$47.74	$59,675.00	367,420
11/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$47.27	$567,240.00	1,071,807
10/23/2023	James George Chopas	CAO	Sell	132	$46.04	$6,077.28	32,680
10/23/2023	Mark Jeffrey DeLong	Insider	Sell	131	$46.04	$6,031.24	51,622
10/17/2023	Alec Machiels	Director	Sell	1,250	$48.50	$60,625.00	367,420
10/9/2023	Pascal Deschatelets	Insider	Sell	12,000	$40.38	$484,560.00	1,066,313
9/18/2023	Alec Machiels	Director	Sell	1,250	$45.00	$56,250.00	367,420
9/18/2023	Nur Nicholson	Insider	Sell	20,350	$44.27	$900,894.50	53,284
9/15/2023	Alec Machiels	Director	Sell	1,250	$45.34	$56,675.00	367,420
9/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$42.87	$514,440.00	1,059,813
9/1/2023	Cedric Francois	CEO	Sell	150,000	$41.75	$6,262,500.00	424,655
8/31/2023	James George Chopas	CAO	Sell	551	$41.23	$22,717.73	30,312
8/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$23.66	$283,920.00	1,053,313
7/17/2023	Alec Machiels	Director	Sell	1,250	$64.79	$80,987.50	267,641
7/10/2023	Pascal Deschatelets	Insider	Sell	12,000	$84.55	$1,014,600.00	1,046,813
7/3/2023	David O. Watson	General Counsel	Sell	8,510	$89.98	$765,729.80	85,753
7/3/2023	Timothy Eugene Sullivan	CFO	Sell	6,779	$89.97	$609,906.63	77,713
6/20/2023	Alec Machiels	Director	Sell	1,250	$88.41	$110,512.50	267,641

SEC Filings (Institutional Ownership Changes) for Apellis Pharmaceuticals (NASDAQ:APLS)

96.29% of Apellis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Apellis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/16/2026	Empowered Funds LLC	148,038	$5.96M	0.0%	+1,006.3%	0.116%
6/15/2026	Carmignac Gestion	35,127	$1.41M	0.0%	N/A	0.027%
5/29/2026	Perceptive Advisors LLC	80,956	$3.26M	0.1%	N/A	0.063%
5/28/2026	Carlson Capital L.P.	30,000	$1.21M	0.4%	N/A	0.023%
5/19/2026	Bank of America Corp DE	1,190,864	$47.91M	0.0%	+24.5%	0.930%
5/19/2026	Janus Henderson Group PLC	252,130	$10.14M	0.0%	+9.5%	0.197%
5/19/2026	Oddo BHF Asset Management Sas	825,000	$33.19M	1.3%	N/A	0.644%
5/18/2026	ADAR1 Capital Management LLC	72,500	$2.92M	0.2%	+262.5%	0.057%
5/18/2026	EverSource Wealth Advisors LLC	1,219	$49K	0.0%	-53.2%	0.001%
5/18/2026	California State Teachers Retirement System	94,833	$3.82M	0.0%	+29.5%	0.074%
5/18/2026	Readystate Asset Management LP	34,100	$1.37M	0.1%	N/A	0.027%
5/18/2026	Royal Bank of Canada	126,701	$5.10M	0.0%	+42.9%	0.099%
5/18/2026	Rock Springs Capital Management LP	162,750	$6.55M	0.4%	+8.1%	0.127%
5/18/2026	Empowered Funds LLC	148,038	$5.96M	0.0%	+1,006.3%	0.116%
5/18/2026	Exome Asset Management LLC	85,517	$3.44M	1.8%	-37.0%	0.067%
5/16/2026	The Manufacturers Life Insurance Company	24,765	$1M	0.0%	+8.4%	0.019%
5/16/2026	Quantinno Capital Management LP	121,270	$4.88M	0.0%	+281.8%	0.095%
5/16/2026	SummitTX Capital L.P.	20,351	$0.82M	0.0%	N/A	0.016%
5/15/2026	Weiss Asset Management LP	700,000	$28.16M	0.5%	N/A	0.547%
5/15/2026	Absolute Gestao de Investimentos Ltda.	450,000	$18.10M	2.1%	N/A	0.352%
5/15/2026	Kryger Capital LLC	1,100,000	$44.25M	3.1%	N/A	0.859%
5/14/2026	Healthcare of Ontario Pension Plan Trust Fund	1,202,100	$48.36M	0.1%	N/A	0.939%
5/14/2026	Renaissance Technologies LLC	935,958	$37.65M	0.1%	+47.8%	0.731%
5/14/2026	Gabelli Funds LLC	321,200	$12.92M	0.1%	N/A	0.251%
5/14/2026	GABELLI & Co INVESTMENT ADVISERS INC.	200,600	$8.07M	1.2%	N/A	0.157%
5/14/2026	Gamco Investors INC. ET AL	21,000	$0.85M	0.0%	N/A	0.016%
5/14/2026	Public Employees Retirement System of Ohio	31,378	$1.26M	0.0%	-3.3%	0.025%
5/14/2026	Capula Management Ltd	56,266	$2.26M	0.0%	N/A	0.044%
5/14/2026	Sei Investments Co.	11,747	$0.47M	0.0%	-80.5%	0.009%
5/14/2026	State of Wyoming	1,288	$52K	0.0%	N/A	0.001%
5/13/2026	Transmarket Holdings LP	23,585	$0.95M	0.5%	N/A	0.018%
5/13/2026	First Trust Advisors LP	903,637	$36.35M	0.0%	+82.2%	0.706%
5/8/2026	PNC Financial Services Group Inc.	54,474	$2.19M	0.0%	+1.8%	0.043%
5/7/2026	Dimensional Fund Advisors LP	1,338,995	$53.75M	0.0%	+640.1%	1.046%
5/5/2026	Bank of New York Mellon Corp	524,789	$21.11M	0.0%	+93.0%	0.410%
5/5/2026	Maryland State Retirement & Pension System	20,816	$0.84M	0.0%	N/A	0.016%
5/4/2026	ABC Arbitrage SA	83,317	$3.35M	0.4%	N/A	0.065%
5/4/2026	Principal Financial Group Inc.	499,053	$20.08M	0.0%	N/A	0.390%
5/4/2026	Teachers Retirement System of The State of Kentucky	25,000	$1.01M	0.0%	N/A	0.020%
5/1/2026	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	25,344	$1.02M	0.0%	N/A	0.020%
5/1/2026	Fifth Third Bancorp	22,102	$0.89M	0.0%	N/A	0.017%
4/30/2026	Hsbc Holdings PLC	5,944	$0.24M	0.0%	N/A	0.005%
4/30/2026	Granite Investment Partners LLC	231,917	$9.33M	0.6%	-29.1%	0.181%
4/30/2026	Oregon Public Employees Retirement Fund	23,400	$0.94M	0.0%	N/A	0.018%
4/29/2026	Burney Co.	61,578	$2.48M	0.1%	N/A	0.048%
4/27/2026	Chicago Capital Management LLC	190,000	$7.64M	0.0%	N/A	0.149%
4/27/2026	New York State Teachers Retirement System	18,299	$0.74M	0.0%	N/A	0.014%
4/27/2026	Y Intercept Hong Kong Ltd	8,536	$0.34M	0.0%	-73.0%	0.007%
4/22/2026	Pictet Asset Management Holding SA	426,821	$17.17M	0.0%	+9.2%	0.334%
4/21/2026	Louisiana State Employees Retirement System	45,400	$1.83M	0.0%	N/A	0.036%
2/19/2026	T. Rowe Price Investment Management Inc.	1,974	$50K	0.0%	-96.0%	0.002%
2/19/2026	Invesco Ltd.	225,976	$5.68M	0.0%	+23.5%	0.179%
2/18/2026	Mercer Global Advisors Inc. ADV	17,668	$0.44M	0.0%	-54.7%	0.014%
2/18/2026	Vident Advisory LLC	15,553	$0.39M	0.0%	-56.0%	0.012%
2/18/2026	Mackenzie Financial Corp	96,211	$2.42M	0.0%	+25.4%	0.076%
2/18/2026	NewEdge Advisors LLC	14,570	$0.37M	0.0%	N/A	0.012%
2/18/2026	Voloridge Investment Management LLC	461,186	$11.59M	0.0%	-53.5%	0.365%
2/18/2026	Virtus Investment Advisers LLC	27,086	$0.68M	0.2%	+17.4%	0.021%
2/18/2026	Twinbeech Capital LP	13,152	$0.33M	0.0%	+47.3%	0.010%
2/18/2026	Sphera Funds Management LTD.	250,961	$6.30M	1.2%	+294.2%	0.198%
2/18/2026	Suvretta Capital Management LLC	4,139,426	$103.98M	2.1%	+43.8%	3.272%
2/18/2026	Quadrature Capital Ltd	24,075	$0.61M	0.0%	N/A	0.019%
2/18/2026	RTW Investments LP	7,666,764	$192.59M	1.9%	N/A	6.059%
2/18/2026	Orbimed Advisors LLC	2,429,868	$61.04M	1.3%	-5.6%	1.920%
2/18/2026	Odyssean LLC	19,207	$0.48M	0.3%	N/A	0.015%
2/18/2026	Millennium Management LLC	946,459	$23.78M	0.0%	-29.6%	0.748%
2/18/2026	Man Group plc	144,271	$3.62M	0.0%	+114.7%	0.114%
2/18/2026	Ishara Investments LP	50,000	$1.26M	1.5%	N/A	0.040%
2/18/2026	Janus Henderson Group PLC	230,320	$5.79M	0.0%	+569.3%	0.182%
2/18/2026	Gotham Asset Management LLC	168,455	$4.23M	0.0%	+32.5%	0.133%
2/18/2026	Elmind Capital LP	50,000	$1.26M	0.4%	N/A	0.040%
2/18/2026	Apis Capital Advisors LLC	192,000	$4.82M	0.8%	N/A	0.152%
2/18/2026	683 Capital Management LLC	330,000	$8.29M	0.4%	+14.6%	0.261%
2/17/2026	Freestone Grove Partners LP	12,537	$0.32M	0.0%	N/A	0.010%
2/17/2026	Guggenheim Capital LLC	36,647	$0.92M	0.0%	+8.3%	0.029%
2/17/2026	AQR Capital Management LLC	2,276,687	$57.19M	0.0%	-49.3%	1.799%
2/17/2026	Jain Global LLC	16,877	$0.42M	0.0%	N/A	0.013%
2/17/2026	Trexquant Investment LP	194,592	$4.89M	0.0%	-66.8%	0.154%
2/17/2026	Amundi	30,721	$0.77M	0.0%	-97.9%	0.024%
2/17/2026	Jump Financial LLC	193,876	$4.87M	0.1%	-30.2%	0.153%
2/17/2026	Price T Rowe Associates Inc. MD	95,035	$2.39M	0.0%	-3.0%	0.075%
2/17/2026	T. Rowe Price Investment Management Inc.	1,974	$50K	0.0%	-96.0%	0.002%
2/17/2026	Rock Springs Capital Management LP	150,500	$3.78M	0.2%	+63.6%	0.119%
2/17/2026	Quantitative Investment Management LLC	8,611	$0.22M	0.0%	N/A	0.007%
2/17/2026	Integral Health Asset Management LLC	200,000	$5.02M	0.2%	-20.0%	0.158%
2/17/2026	Public Employees Retirement System of Ohio	32,448	$0.82M	0.0%	-3.7%	0.026%
2/17/2026	State of Wisconsin Investment Board	66,916	$1.68M	0.0%	-22.0%	0.053%
2/17/2026	ExodusPoint Capital Management LP	171,156	$4.30M	0.0%	-12.1%	0.135%
2/17/2026	Royal Bank of Canada	88,687	$2.23M	0.0%	-39.3%	0.070%
2/17/2026	Graham Capital Management L.P.	9,302	$0.23M	0.0%	-59.9%	0.007%
2/17/2026	Polar Capital Holdings Plc	3,706,510	$93.11M	0.4%	+39.9%	2.929%
2/16/2026	Squarepoint Ops LLC	192,156	$4.83M	0.0%	+140.7%	0.152%
2/16/2026	Panagora Asset Management Inc.	42,134	$1.06M	0.0%	N/A	0.033%
2/16/2026	Maven Securities LTD	15,000	$0.38M	0.0%	N/A	0.012%
2/16/2026	Entropy Technologies LP	23,128	$0.58M	0.0%	-6.0%	0.018%
2/13/2026	Marshall Wace LLP	990,848	$24.89M	0.0%	+149.8%	0.783%
2/13/2026	CANADA LIFE ASSURANCE Co	8,495	$0.21M	0.0%	-52.1%	0.007%
2/13/2026	Bridgewater Associates LP	143,805	$3.61M	0.0%	N/A	0.114%
2/13/2026	Stifel Financial Corp	36,661	$0.92M	0.0%	N/A	0.029%
2/13/2026	Hudson Bay Capital Management LP	1,179,828	$29.64M	0.1%	+181.9%	0.932%

Data available starting January 2016

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, and hematopoietic stem cell transplantation-associated thrombotic microangiopathy; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops APL-3007, a small interfering RNA, or siRNA, which is in a Phase 1 clinical trial, as well as an oral complement inhibitor that is in preclinical development. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

Today's Range

Now: $41.03

$41.03

$41.07

50 Day Range

MA: $34.89

$16.97

$41.12

52 Week Range

Now: $41.03

$16.10

$41.14

Volume

68,611,400 shs

Average Volume

7,541,235 shs

Market Capitalization

$5.25 billion

P/E Ratio

40.23

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Apellis Pharmaceuticals?: Apellis Pharmaceuticals' top insider investors include:
Pascal Deschatelets (Insider)
Cedric Francois (CEO)
Alec Machiels (Director)
A Sinclair Dunlop (Director)
David O Watson (General Counsel)
Timothy Eugene Sullivan (CFO)
Mark Jeffrey Delong (Insider)
Federico Grossi (Insider)
Adam J Townsend (Insider)
Caroline Baumal (Insider)
Learn More about top insider investors at Apellis Pharmaceuticals.
Who are the major institutional investors of Apellis Pharmaceuticals?: Apellis Pharmaceuticals' top institutional shareholders include:
Dimensional Fund Advisors LP — 1.05%
Healthcare of Ontario Pension Plan Trust Fund — 0.94%
Bank of America Corp DE — 0.93%
Kryger Capital LLC — 0.86%
Renaissance Technologies LLC — 0.73%
First Trust Advisors LP — 0.71%
Learn More about top institutional investors of Apellis Pharmaceuticals stock.
Which institutional investors are selling Apellis Pharmaceuticals stock?: Within the last quarter, APLS stock was sold by these institutional investors:
Granite Investment Partners LLC
Exome Asset Management LLC
Sei Investments Co.
Y Intercept Hong Kong Ltd
EverSource Wealth Advisors LLC
Public Employees Retirement System of Ohio
In the last year, company insiders that have sold Apellis Pharmaceuticals company stock include:
Pascal Deschatelets (Insider)
Cedric Francois (CEO)
David O Watson (General Counsel)
Mark Jeffrey Delong (Insider)
Timothy Eugene Sullivan (CFO)
Caroline Baumal (Insider)
Nur Nicholson (Insider)
A Sinclair Dunlop (Director)
James George Chopas (CAO)
Learn More investors selling Apellis Pharmaceuticals stock.
Which institutional investors are buying Apellis Pharmaceuticals stock?: During the previous quarter, APLS stock was purchased by institutional investors including:
Healthcare of Ontario Pension Plan Trust Fund
Dimensional Fund Advisors LP
Kryger Capital LLC
Oddo BHF Asset Management Sas
Weiss Asset Management LP
Principal Financial Group Inc.
Absolute Gestao de Investimentos Ltda.
First Trust Advisors LP